(267) 225-7191
Learn More
About Us
Christopher Gibson, V.m.d., Ph.D., DaCVP
Position: President & CEO
Dr. Gibson is a board certified (ACVP) veterinary pathologist with experience in research pathology, pharmaceutical/biotech industry, chemical industry, and gene therapy. He began his career at Rutgers University studying molecular mechanisms of Parkinson disease and collaborating with researchers to provide pathology assessment in areas of environmental toxicology, neurodegenerative diseases, and cancer research. Later he joined the discovery pathology groups at Merck Research Labs in Palo Alto, California. At Merck he was involved in designing and validating assays in their high-profile biologics discovery division. He served as pathologist and subject matter expert on multiple biologics discovery teams. He was involved in several internal and outside collaborations evaluating potential clinical immunohistochemistry biomarkers. At Merck, Dr. Gibson was involved extensively in evaluating immunohistochemistry, immunofluorescence, in-situ hybridization, target validation, tissue cross-reactivity, biodistribution, cross-species comparison (mouse, cynomolgus, rhesus, human). He was also involved in generating data and preparing manuscripts for target dossiers, internal seminars, and technical documents for regulatory filing.
Dr. Gibson later worked for DuPont in the Science and Technology division at Haskell Global Centers for Health and Environmental Sciences. At DuPont, Dr. Gibson evaluated toxicology studies ranging from acute studies to multi-generation studies. Dr. Gibson served as consultant on many projects in both the DuPont/Crop Protection business and for DuPont/Pioneer. Dr. Gibson established automated immunohistochemistry, digital pathology, and quantitative image analysis capabilities.
Dr. Gibson has an extensive background in molecular biology and a Ph.D. in Toxicology from Rutgers, The State University of New Jersey. He also has unique expertise with evaluating efficacy and safety in the fast-growing field of gene therapy. This unique combination of experience and expertise enables seamless communication and understanding between all aspects of the discovery team. This ensures that your best-interests are always top priority.
Total Pathology Solutions, LLC provides high-quality, full-service pathology services as an alternative to the traditional contract research organization (CRO). The idea is to provide the service, commitment, and expertise that can only come from having a dedicated in-house pathologist.